Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 20, 2026

Nervous About the Iran War Uncertainty? This Stock Has Been Rock Solid Over the Last Two Months

View original at nasdaq.com
Nervous About the Iran War Uncertainty? This Stock Has Been Rock Solid Over the Last Two Months Key Points Stocks remain volatile as Iran just closed down the Strait of Hormuz again…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If you invested $1,000 in Nvidia on April 15, 2005, you'd have $1,236,406 as of April 20, 2026

    60% confidence
  • For investors looking for a safe stock to ride out the storm in the Middle East, Costco looks like an excellent choice

    60% confidence
  • If you invested $1,000 in Netflix on December 17, 2004, you'd have $524,786 as of April 20, 2026

    60% confidence
  • Costco Wholesale was not among the 10 best stocks for investors to buy now

    60% confidence
  • The two-week ceasefire is unlikely to be extended

    60% confidence

Data points we hold from this source

S&P 500 · total return comparison period199 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com